Press releases
- Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
- Penumbra, Inc. to Present at the Truist Securities MedTech Conference
- Penumbra, Inc. to Present at the William Blair Growth Stock Conference
- Penumbra, Inc. Reports First Quarter 2024 Financial Results
- Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
More ▼
Key statistics
As of last trade Penumbra Inc (0P8:BRN) traded at 239.06, 0.00% below its 52-week high of 239.06, set on Sep 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 239.06 |
---|---|
High | 239.06 |
Low | 239.06 |
Bid | 237.17 |
Offer | 239.09 |
Previous close | 239.06 |
Average volume | -- |
---|---|
Shares outstanding | 38.76m |
Free float | 37.29m |
P/E (TTM) | 85.50 |
Market cap | 7.88bn USD |
EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Sep 15 2023.
More ▼